Clinical Trial Update: Phase I Clinical Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics of NTB003 in Healthy Participants [Phase 1]

View source ↗

Summary

Phase I study to evaluate safety, pharmacokinetics, and pharmacodynamics of NTB003 in healthy participants. Thyroid eye disease is listed as the related indicat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Eye Disease

Drugs mentioned

• NTB003

Snippet

Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical | Conditions: TED | Phase 1 | Status: ENROLLING_BY_INVITATION